tiprankstipranks
Blurbs

Analysts’ Opinions Are Mixed on These Technology Stocks: Keysight Technologies (KEYS), Grab (GRAB) and Model N (MODN)

Analysts have been eager to weigh in on the Technology sector with new ratings on Keysight Technologies (KEYSResearch Report), Grab (GRABResearch Report) and Model N (MODNResearch Report).

Keysight Technologies (KEYS)

In a report issued on November 21, Samik Chatterjee from J.P. Morgan maintained a Buy rating on Keysight Technologies, with a price target of $153.00. The company’s shares closed last Wednesday at $135.72.

According to TipRanks.com, Chatterjee is a 5-star analyst with an average return of 8.6% and a 54.3% success rate. Chatterjee covers the Technology sector, focusing on stocks such as Hewlett Packard Enterprise, Dell Technologies, and Juniper Networks.

Keysight Technologies has an analyst consensus of Moderate Buy, with a price target consensus of $155.22, a 14.8% upside from current levels. In a report issued on November 10, Citi also maintained a Buy rating on the stock with a $165.00 price target.

See Insiders’ Hot Stocks on TipRanks >>

Grab (GRAB)

In a report issued on November 21, Ranjan Sharma from J.P. Morgan maintained a Hold rating on Grab, with a price target of $3.15. The company’s shares closed last Wednesday at $3.13.

Sharma has an average return of 0.9% when recommending Grab.

According to TipRanks.com, Sharma is ranked #6345 out of 8631 analysts.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Grab with a $4.41 average price target.

Model N (MODN)

In a report issued on November 20, Anne Samuel from J.P. Morgan maintained a Buy rating on Model N, with a price target of $30.00. The company’s shares closed last Wednesday at $23.72, close to its 52-week low of $20.90.

According to TipRanks.com, Samuel is a 4-star analyst with an average return of 14.4% and a 42.5% success rate. Samuel covers the Healthcare sector, focusing on stocks such as Definitive Healthcare Corp, IQVIA Holdings, and Evolent Health.

Currently, the analyst consensus on Model N is a Moderate Buy with an average price target of $30.50, representing a 28.7% upside. In a report issued on November 10, Craig-Hallum also maintained a Buy rating on the stock with a $30.00 price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on KEYS:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles